This is a huge step for FSD Pharma:
FSD Pharma (OTCQB:FSDDF) released news this morning that its shares had been approved for listing on the Nasdaq exchange. Big news for a company which, to date, was seen primarily as a Canadian venture. The Nasdaq listing reflects the company’s ongoing commitment to the American pharmaceutical market.
As well as yesterday’s announcement of a collaboration with Solarvest BioEnergy Inc to research using its algal expression technology to develop pharmaceutical-grade cannabinoids, FSD Pharma (CSE.HUGE) is also involved with Aura Health Inc. (CSE:BUZZ). This collaboration will give FSD Pharma a window into the medical marijuana market in Germany and, eventually, the EU generally.